Resveratrol based supplement reverses vision loss from macular degeneration
An unstudied resveratrol based nutriceutical treatment was able to restore vision in patients with the wet form of macular degeneration, according to a report from Stuart Richer OD, PhD, Director, Ocular Preventative Medicine-Eye Clinic, James A. Lovell Federal Health Care Center, North Chicago, Illinois.
Dr. Richer reports he treated patients who had not responded to angiogenesis inhibitors - injectable drugs - with the supplement Longevinex®.
Wet macular degeneration, the most aggressive wet form, leads to blindness because of blood vessel proliferation that leads to ‘blind spots’. Angiogenesis is a term that simply means the growth of new blood vessels.
Nutriceutical rapidly restores vision
According to Richer, one in three patients fails to respond to the injectable drug; some refuse drug injections which are given directly into the eye and one in six patients still lose their vision despite angiogenesis inhibitor therapy. Examples of FDA approved drugs for treating macular degeneration include Avastin, Lucentis and Eylea.
In an effort to help patients who were facing permanent vision loss, and as a last resort, he used in 17 patients, 16 of whom responded positively.
He presented three cases at the annual Association For Research In Vision & Ophthalmology meeting in Ft. Lauderdale, Florida.
One case presented involved an 88 year old woman who was hospitalized. After four days of taking the nutriceutical supplement she was able to read a menu and see her handwriting and faces. Richer says she had failed conventional medical therapy for macular degeneration treatment and surgery.
Another patient, a 75 year old man, recovered vision in 5 days and obtained a renewed driver’s license after 7 days of taking the nutriceutical.
Dr. Richer said in a press release, “this oral nutriceutical taps into the newly appreciated science of epigenetics, where gene protein-making switches are favorably turned on and off, and suggests that age-related eye problems may not be inevitably progressive and biological age is not necessarily cast in stone.” There is new-found hope for recovery of lost vision, regardless of the patient’s image.”